{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T21:10:53Z","timestamp":1769461853541,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ajem.2021.06.044","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T07:32:23Z","timestamp":1624519943000},"page":"304-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["The prevalence and predictors of extended spectrum B-lactamase urinary tract infections among emergency department patients: A retrospective chart review"],"prefix":"10.1016","volume":"49","author":[{"given":"Ralphe","family":"Bou Chebl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Assaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadim","family":"Kattouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samer","family":"Abou Arbid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saadeddine","family":"Haidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirabelle","family":"Geha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Makki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Tamim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilbert","family":"Abou Dagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2021.06.044_bb0005","author":"NAMCS\/NHAMCS"},{"key":"10.1016\/j.ajem.2021.06.044_bb0010","series-title":"Open forum infectious diseases","article-title":"The increase in hospitalizations for urinary tract infections and the associated costs in the United States, 1998\u20132011","volume":"vol. 4","author":"Simmering","year":"2017"},{"issue":"9","key":"10.1016\/j.ajem.2021.06.044_bb0015","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3201\/eid2209.160148","article-title":"EMERGEncy ID Net Study Group. Fluoroquinolone-resistant and extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli infections in patients with pyelonephritis, United States","volume":"22","author":"Talan","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.ajem.2021.06.044_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.annemergmed.2018.05.006","article-title":"Emergency Department Urinary Tract Infections Caused by Extended-Spectrum \u03b2-Lactamase-Producing Enterobacteriaceae: Many Patients Have No Identifiable Risk Factor and Discordant Empiric Therapy Is Common","volume":"72","author":"Frazee","year":"2018","journal-title":"Ann Emerg Med."},{"issue":"1","key":"10.1016\/j.ajem.2021.06.044_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/502298","article-title":"Clinical and microbiological profile of urinary tract infection at a tertiary-care center in Lebanon","volume":"25","author":"Fadel","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajem.2021.06.044_bb0030","article-title":"Escherichia coli isolated from urinary tract infections of Lebanese patients between 2000 and 2009: epidemiology and profiles of resistance","volume":"2011","author":"Daoud","year":"2011","journal-title":"Chemother Res Pract"},{"issue":"2","key":"10.1016\/j.ajem.2021.06.044_bb0035","first-page":"227","article-title":"Factors associated with extended spectrum [beta]-lactamase producing Escherichia coli in community-acquired urinary tract infection at hospital emergency department, Bangkok, Thailand","volume":"47","author":"Savatmongkorngul","year":"2016","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.ajem.2021.06.044_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcimb.2015.00045","article-title":"Epidemiology and characteristics of urinary tract infections in children and adolescents","volume":"5","author":"Hanna-Wakim","year":"2015","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.ajem.2021.06.044_bb0045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ajic.2005.03.009","article-title":"Epidemiology and risk factors for extended-spectrum \u03b2-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon","volume":"33","author":"Kanafani","year":"2005","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ajem.2021.06.044_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1874285801711010023","article-title":"ESBL production among and spp. Causing urinary tract infection: a hospital based study","volume":"11","author":"Shakya","year":"2017","journal-title":"Open Microbiol J"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.044_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1001\/jama.281.1.67","article-title":"Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU study groups","volume":"281","author":"Hanberger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2021.06.044_bb0060","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13756-018-0309-1","article-title":"Prevalence of extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan","volume":"7","author":"Abrar","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.044_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000109587","article-title":"Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates","volume":"17","author":"Al-Zarouni","year":"2008","journal-title":"Med Princ Pract"},{"issue":"3","key":"10.1016\/j.ajem.2021.06.044_bb0070","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4269\/ajtmh.18-0396","article-title":"Molecular characterization of extended-Spectrum \u03b2-lactamase Enterobacteriaceae isolated from Egyptian patients with community-and hospital-acquired urinary tract infection","volume":"100","author":"Shash","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ajem.2021.06.044_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.tmaid.2018.01.007","article-title":"Community-acquired urinary tract infections due to extended-spectrum \u03b2-lactamase-producing organisms in United Arab Emirates","volume":"22","author":"Dash","year":"2018","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.044_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.annemergmed.2020.08.022","article-title":"Emergence of extended-spectrum \u03b2-lactamase urinary tract infections among hospitalized emergency department patients in the United States","volume":"77","author":"Talan","year":"2021","journal-title":"Ann Emerg Med"},{"issue":"9","key":"10.1016\/j.ajem.2021.06.044_bb0085","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ajem.2018.01.046","article-title":"Risk factors of urinary tract infection caused by extended spectrum \u03b2-lactamase-producing Escherichia coli in emergency department","volume":"36","author":"Lee","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2021.06.044_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.044_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/ice.2015.239","article-title":"Increasing incidence of extended-spectrum \u03b2-lactamase-producing Escherichia coli in community hospitals throughout the southeastern United States","volume":"37","author":"Thaden","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.ajem.2021.06.044_bb0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Spanish network for research in infectious diseases (REIPI). Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"Rodr\u00edguez-Ba\u00f1o","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.ajem.2021.06.044_bb0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jinf.2015.11.009","article-title":"ONERBA-ville network. Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in community-onset urinary tract infections in France in 2013","volume":"72","author":"Martin","year":"2016","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.ajem.2021.06.044_bb0110","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/604713","article-title":"A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients","volume":"49","author":"Ben-Ami","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ajem.2021.06.044_bb0115","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1742-1241.2012.02991.x","article-title":"Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria","volume":"66","author":"Briongos-Figuero","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ajem.2021.06.044_bb0120","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/QCO.0b013e3283398dc1","article-title":"Extended-spectrum beta-lactamase producing Escherichia coli: changing epidemiology and clinical impact","volume":"23","author":"Oteo","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ajem.2021.06.044_bb0125","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jmii.2015.10.001","article-title":"Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: a threat of extended spectrum beta-lactamase-producers among nursing home residents","volume":"49","author":"Liu","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ajem.2021.06.044_bb0130","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhin.2014.07.009","article-title":"Service evaluation of selected risk factors for extended-spectrum beta-lactamase Escherichia coli urinary tract infections: a case-control study","volume":"88","author":"Inns","year":"2014","journal-title":"J Hosp Infect"},{"issue":"8","key":"10.1016\/j.ajem.2021.06.044_bb0135","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes","volume":"32","author":"Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ajem.2021.06.044_bb0140","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","article-title":"Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment","volume":"51","author":"Tumbarello","year":"2007","journal-title":"Antimicrob Agents Chemother"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721005283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675721005283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:56:29Z","timestamp":1760025389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675721005283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"alternative-id":["S0735675721005283"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.06.044","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence and predictors of extended spectrum B-lactamase urinary tract infections among emergency department patients: A retrospective chart review","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.06.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}